Author(s): Stevens O, Anderson R, Stover J, Teng Y, Stannah J, Silhol R, Jones H, Booton RD, Martin-Hughes R, Johnson L, Maheu-Giroux M, Mishra S, Stone J, Bershteyn A, Kim HY, Sabin K, Mitchell KM, Dimitrov D, Baral S, Donnell D, Korenromp E, Rice B, Hargreaves JR, Vickerman P, Boily MC, Imai-Eaton JW|Journal: J Acquir Immune Defic Syndr|PMID:38180738| January 2024
The distribution of new HIV infections among key populations, including female sex workers (FSWs), gay men and other men who…
Author(s): Silhol R, Anderson RL, Stevens O, Stannah J, Booton RD, Baral S, Dimitrov D, Mitchell KM, Donnell D, Bershteyn A, Brown T, Kelly SL, Kim HY, Johnson LF, Maheu-Giroux M, Martin-Hughes R, Mishra S, Peerapatanapokin W, Stone J, Stover J, Teng Y, Vickerman P, Garcia SA, Korenromp E, Imai-Eaton JW, Boily MC|Journal: J Acquir Immune Defic Syndr|PMID:38180739| January 2024
Key populations (KPs), including female sex workers (FSWs), gay men and other men who have sex with men (MSM), people…
Author(s): Stevens O, Boothe M, Tiberi O, Mahy M, Walker P, Glaubius R, McOwen J, Couto A, Cunha M, Imai-Eaton JW|Journal: J Acquir Immune Defic Syndr|PMID:38180740| January 2024
Routine health system data are central to monitoring HIV trends. In Mozambique, the reported number of women receiving antenatal care…
Author(s): Trickey A, Glaubius R, Pantazis N, Zangerle R, Wittkop L, Vehreschild J, Grabar S, Cavassini M, Teira R, d'Arminio Monforte A, Casabona J, van Sighem A, Jarrin I, Ingle SM, Sterne JAC, Imai-Eaton JW, Johnson LF|Journal: J Acquir Immune Defic Syndr|PMID:38180742| January 2024
Mortality rates for people living with HIV (PLHIV) on antiretroviral therapy (ART) in high-income countries continue to decline. We compared…
Author(s): Liu AB, Lee D, Jalihal AP, Hanage WP, Springer M|Journal: Nat Commun|PMID:38123536| December 2023
Researchers and policymakers have proposed systems to detect novel pathogens earlier than existing surveillance systems by monitoring samples from hospital…
Immunocompromised patients receiving B-cell-depleting therapies are at increased risk of persistent SARS-CoV-2 infection, with many experiencing fatal outcomes. We report…